StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) stock

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30111% above fair value
$56.30+1.31 (+2.38%)

Close on Nov 17, 2026Market cap $7.34BP/E –Yield –

10x Genomics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

10x Genomics's price to book ratio was 9.6× on Nov 11, 2026, against 3.0× a year earlier. Over the last 5 years it ranged from 1.4× to 20.3×, with a median of 5.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.6×+7.0
2025Dec 31, 20252.6×+0.2
2024Dec 31, 20242.4×−6.3
2023Dec 29, 20238.7×+3.4
2022Dec 30, 20225.3×−15.0
2021Dec 31, 202120.3×+2.2
2020Dec 31, 202018.1×+0.7
2019Dec 31, 201917.4×–

More 10x Genomics figures

See a number that looks wrong?